Adrenergic Receptor Modulation of Non-Motor Symptoms in Parkinson’s Disease
Objective: To analyze the correlation between the use of beta-blockers (BB) and the prevalence of non-motor symptoms in patients with Parkinson’s disease (PD). Background: In…Is Dizziness a sign before DLB onset?
Objective: I noticed that outpatients often continually complain about symptoms not found in PDD in DLB patients. In this time, I traced back the clinical…Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication
Objective: To examine 36-month effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms (NMS) and self-reported quality of life compared to…“Familial imprint” of Parkinson disease: the siblings’ cohort of PROPAG-AGEING
Objective: To verify if non-affected siblings (Sibs) of PD patients share candidate PD biomarkers in comparison with de-novo PD patients (PD) and healthy controls (HC).…Data quality, acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)
Objective: To analyze the acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS). Background: Parkinson’s disease (PD) is a chronic…Quantitative Susceptibility Mapping: an Biomarker for Diagnosis of Parkinson’s Disease and Evaluation Patients’ Condition
Objective: To study deep gray matter susceptibility in Parkinson's Disease (PD) by using quantitative susceptibility mapping (QSM) and to assess the relationship between susceptibility value…Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease
Objective: To identify the advantages of LCIG in the treatment of NMS among APD patients and appraise the currently available literature to identify the gaps…Carotid Intima-Media Thickness and its correlates in people with Parkinson’s disease: a pilot study
Objective: To determine the clinical correlates of carotid intima media thickess in patients with idiopathic Parkinson’s disease (PD). Background: Subclinical cardiovascular disease has been suggested…Hyposmia as a marker of (non-)motor disease progression in Parkinson’s disease
Objective: To determine the relationship of anosmia/hyposmia in Parkinson’s disease (PD) with other motor and non-motor symptoms, and with the degree of nigrostriatal dopaminergic cell…Developing an innovative telephone support line for people with Parkinson’s Disease
Objective: To develop a novel care approach using a nurse led telephone helpline specialized and dedicated to persons with Parkinson’s Disease (PD). Background: PD is…
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 55
- Next Page »